Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2011 4
2012 1
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults.
Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, Shafran S, Zubyk W, Singer J, Halperin S, Walmsley S; CIHR Canadian HIV Trials Network Influenza Vaccine Research Group. Cooper C, et al. PLoS One. 2011 Mar 25;6(3):e17758. doi: 10.1371/journal.pone.0017758. PLoS One. 2011. PMID: 21512577 Free PMC article. Clinical Trial.
Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
Thorne A, Chowdhury F, Singer J, Keynan Y, Fowke KR, Cooper C; CIHR Canadian HIV Trials Network (CTN) Influenza Vaccine Research Group. Thorne A, et al. Vaccine. 2016 Jun 30;34(31):3584-91. doi: 10.1016/j.vaccine.2016.05.020. Epub 2016 May 19. Vaccine. 2016. PMID: 27211040 Clinical Trial.
The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.
Nosyk B, Sharif B, Sun H, Cooper C, Anis AH; CIHR Canadian HIV Trials Network Influenza Vaccine Research Group. Nosyk B, et al. PLoS One. 2011;6(12):e27059. doi: 10.1371/journal.pone.0027059. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22162988 Free PMC article. Clinical Trial.
Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines.
Jacobson RM, Swan A, Adegbenro A, Ludington SL, Wollan PC, Poland GA; Vaccine Research Group. Jacobson RM, et al. Vaccine. 2001 Mar 21;19(17-19):2418-27. doi: 10.1016/s0264-410x(00)00466-7. Vaccine. 2001. PMID: 11257372 Review.
Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults.
Cooper C, Thorne A; Canadian Hiv Trials Network Ctn Influenza Vaccine Research Group. Cooper C, et al. HIV Clin Trials. 2011 Sep-Oct;12(5):275-6. doi: 10.1310/hct1205-275. HIV Clin Trials. 2011. PMID: 22180525 Clinical Trial.
Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.
Peña J, Frías M, Castro-Orgaz L, González R, García F, Gallart T, Gatell JM, Plana M; Dc2-Manon07 Vaccine Research Group. Peña J, et al. Viral Immunol. 2012 Feb;25(1):37-44. doi: 10.1089/vim.2011.0044. Epub 2012 Jan 10. Viral Immunol. 2012. PMID: 22233253 Free PMC article. Clinical Trial.
Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
Cooper C, Thorne A; Canadian Institutes of Health Research-Canadian HIV Trials Network (CTN) Influenza Vaccine Research Group. Cooper C, et al. Vaccine. 2011 Oct 19;29(45):7876-7. doi: 10.1016/j.vaccine.2011.08.066. Epub 2011 Aug 26. Vaccine. 2011. PMID: 21872629 Clinical Trial.
Feedback